美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Odyssey Therapeutics

21.99

-2.2700-9.36%

成交量：27.66萬

成交額：631.09萬

市值：10.56億

市盈率：-6.58

高：24.84

開：24.31

低：21.72

收：24.26

52周最高：29.05

52周最低：15.10

股本：4,803.13萬

流通股本：1,324.00萬

量比：1.38

換手率：2.09%

股息：- -

股息率：- -

每股收益(TTM):-3.3410

每股收益(LYR):-50.1297

淨資產收益率：-85.50%

總資產收益率：-41.66%

市淨率：2.51

市盈率(LYR):-0.44

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Odyssey Therapeutics

交易所：

NASDAQ

成立時間：

2021

員工人數：

100

公司地址：

51 Sleeper Street,Suite 800,Boston,Massachusetts,United States

官網：

http://odysseytx.com

郵編：

02210

電話：

傳真：

- -

簡介：

Odyssey Therapeutics, Inc.於2021年4月在特拉華州註冊成立。Odyssey是一家臨床階段的生物製藥公司，由一個尋求改變自身免疫性和炎症性疾病患者護理標準的藥物獵手團隊和董事會領導。為了實現這一目標，該公司正在開發旨在精確針對疾病病理的藥物，最初的重點是先天免疫系統。該公司相信，他們對免疫生物學的深刻理解，加上在藥物、計算和蛋白質化學、結構生物學、遺傳學和藥理學方面的領先專業知識，使他們能夠識別和藥物驅動疾病的關鍵信號節點。

董事

名稱

職位

Gary D. Glick

Chief Executive Officer and Director and President

Carolyn Ng

Independent Director

Ian F. Smith

Independent Director

Jeffrey M. Leiden

Chair and Independent Director

Ksenija Pavletic

Independent Director

Nan Li

Independent Director

Nia Tatsis

Independent Director

Paulina Hill

Independent Director

Shelley Chu

Independent Director

Timothy P. Walbert

Independent Director

Valerie Odegard

Independent Director

股東

名稱

職位

Gary D. Glick

Chief Executive Officer and Director and President

Collin Todd

Senior Vice President, Strategy and Business Development

Jason Haas

Chief Financial Officer

Anthony Opipari

Executive Vice President, Translational Medicine and Interim Chief Medical Officer

Jolie M. Siegel

Executive Vice President and General Counsel and Secretary

Natalie Dales

Chief of Research Operations and Portfolio Strategy

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/ODTX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ODTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODTX\",,,,,undefined,":{"symbol":"ODTX","market":"US","secType":"STK","nameCN":"Odyssey Therapeutics","latestPrice":21.99,"timestamp":1789502400000,"preClose":24.26,"halted":0,"volume":276551,"delay":0,"changeRate":-0.0935696619950537,"floatShares":13240000,"shares":48031300,"eps":-3.341,"marketStatus":"盤前交易","change":-2.27,"latestTime":"09-16 06:18:42 EDT","open":24.31,"high":24.835,"low":21.72,"amount":6310868.377308001,"amplitude":0.128401,"askPrice":35.18,"askSize":200,"bidPrice":20.5,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-3.341,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"listingDate":1778212800000,"exchange":"NASDAQ","adjPreClose":21.99,"postHourTrading":{"tag":"盘后","latestPrice":21.4,"preClose":21.99,"latestTime":"17:37 EDT","volume":4411,"amount":95736.77,"timestamp":1789508242246,"change":-0.59,"changeRate":-0.02683,"amplitude":0.02683},"volumeRatio":1.3802090095825057},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODTX\",,,,,undefined,":{"symbol":"ODTX","floatShares":13240000,"roa":"-41.66%","roe":"-85.50%","lyrEps":-50.129685,"volumeRatio":1.3802090095825057,"shares":48031300,"dividePrice":0,"high":24.835,"amplitude":0.128401,"preClose":24.26,"low":21.72,"week52Low":15.1,"pbRate":"2.51","psRate":"10668.77","week52High":29.05,"institutionHeld":0,"latestPrice":21.99,"committee":0.666667,"eps":-3.341,"divideRate":0,"volume":276551,"delay":0,"ttmEps":-3.341,"open":24.31,"prevYearClose":18,"prevWeekClose":24.63,"prevMonthClose":24.52,"prevQuarterClose":18.71,"fiveDayClose":26.97,"twentyDayClose":20.86,"sixtyDayClose":19.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ODTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ODTX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ODTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ODTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1787889600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ODTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ODTX","date":"2026-09-15","current":-6.581862,"percent":0.172414,"low":-8.61189,"twenty":-6.941792,"median":-5.822147,"eighty":-5.419923,"high":-5.017591,"avg":-6.115578,"sd":0.850776,"marketCap":1162501815},"quantilePoints":[{"date":"2026-05-08","current":-5.722186,"twenty":-5.722186,"median":-5.722186,"eighty":-5.722186,"marketCap":850585842},{"date":"2026-05-15","current":-5.496622,"twenty":-5.693383,"median":-5.609284,"eighty":-5.496622,"marketCap":817056381},{"date":"2026-05-22","current":-5.629912,"twenty":-5.680689,"median":-5.537878,"eighty":-5.38396,"marketCap":836869527},{"date":"2026-05-29","current":-5.687036,"twenty":-5.681958,"median":-5.553746,"eighty":-5.441085,"marketCap":845360875},{"date":"2026-06-05","current":-5.395068,"twenty":-5.640067,"median":-5.507729,"eighty":-5.381104,"marketCap":801960652},{"date":"2026-06-12","current":-5.33477,"twenty":-5.599446,"median":-5.433151,"eighty":-5.365236,"marketCap":792997562},{"date":"2026-06-18","current":-5.864756,"twenty":-5.646414,"median":-5.455366,"eighty":-5.369045,"marketCap":871778402},{"date":"2026-06-26","current":-5.739918,"twenty":-5.704904,"median":-5.528358,"eighty":-5.374757,"marketCap":852228560},{"date":"2026-07-02","current":-5.356182,"twenty":-5.790223,"median":-5.545812,"eighty":-5.374122,"marketCap":795253729},{"date":"2026-07-10","current":-5.427125,"twenty":-5.732825,"median":-5.496622,"eighty":-5.359042,"marketCap":805786891},{"date":"2026-07-17","current":-5.501292,"twenty":-5.710665,"median":-5.510065,"eighty":-5.36714,"marketCap":816798833},{"date":"2026-07-24","current":-5.697997,"twenty":-5.732825,"median":-5.553746,"eighty":-5.374122,"marketCap":846004419},{"date":"2026-07-31","current":-5.939848,"twenty":-5.856557,"median":-5.572788,"eighty":-5.377217,"marketCap":881912925},{"date":"2026-08-07","current":-6.447481,"twenty":-5.942427,"median":-5.59659,"eighty":-5.382058,"marketCap":1031771093},{"date":"2026-08-14","current":-6.204393,"twenty":-6.026914,"median":-5.668975,"eighty":-5.382691,"marketCap":992870470},{"date":"2026-08-21","current":-7.387181,"twenty":-6.093162,"median":-5.678649,"eighty":-5.386182,"marketCap":1182148383},{"date":"2026-08-28","current":-7.779447,"twenty":-6.206789,"median":-5.687036,"eighty":-5.395703,"marketCap":1244921564},{"date":"2026-09-04","current":-7.905212,"twenty":-6.445274,"median":-5.710091,"eighty":-5.402083,"marketCap":1265047317},{"date":"2026-09-11","current":-7.078758,"twenty":-6.638581,"median":-5.780226,"eighty":-5.417451,"marketCap":1132792370},{"date":"2026-09-15","current":-7.26441,"twenty":-6.941792,"median":-5.822147,"eighty":-5.419923,"marketCap":1162501815}],"updateTime":1789553922391},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1685251854,"yearFounded":2021,"employeeNum":100,"address":"51 Sleeper Street,Suite 800,Boston,Massachusetts,United States","zipCode":"02210","officePhone":"617 865 9628","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://odysseytx.com","stockEarnings":[{"period":"1week","weight":-0.1846},{"period":"1month","weight":0.0608},{"period":"3month","weight":0.1899},{"period":"6month","weight":0.2217},{"period":"ytd","weight":0.2217}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":-0.0244},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.1479},{"period":"1year","weight":0.146},{"period":"ytd","weight":0.1107}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Odyssey Therapeutics, Inc.於2021年4月在特拉華州註冊成立。Odyssey是一家臨床階段的生物製藥公司，由一個尋求改變自身免疫性和炎症性疾病患者護理標準的藥物獵手團隊和董事會領導。為了實現這一目標，該公司正在開發旨在精確針對疾病病理的藥物，最初的重點是先天免疫系統。該公司相信，他們對免疫生物學的深刻理解，加上在藥物、計算和蛋白質化學、結構生物學、遺傳學和藥理學方面的領先專業知識，使他們能夠識別和藥物驅動疾病的關鍵信號節點。","exchange":"NASDAQ","name":"Odyssey Therapeutics","nameEN":"Odyssey Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ODTX\",market:\"US\",,,undefined,":{"directors":[{"name":"Gary D. Glick","position":"Chief Executive Officer and Director and President"},{"name":"Carolyn Ng","position":"Independent Director"},{"name":"Ian F. Smith","position":"Independent Director"},{"name":"Jeffrey M. Leiden","position":"Chair and Independent Director"},{"name":"Ksenija Pavletic","position":"Independent Director"},{"name":"Nan Li","position":"Independent Director"},{"name":"Nia Tatsis","position":"Independent Director"},{"name":"Paulina Hill","position":"Independent Director"},{"name":"Shelley Chu","position":"Independent Director"},{"name":"Timothy P. Walbert","position":"Independent Director"},{"name":"Valerie Odegard","position":"Independent Director"}],"executives":[{"name":"Gary D. Glick","position":"Chief Executive Officer and Director and President"},{"name":"Collin Todd","position":"Senior Vice President, Strategy and Business Development"},{"name":"Jason Haas","position":"Chief Financial Officer"},{"name":"Anthony Opipari","position":"Executive Vice President, Translational Medicine and Interim Chief Medical Officer"},{"name":"Jolie M. Siegel","position":"Executive Vice President and General Counsel and Secretary"},{"name":"Natalie Dales","position":"Chief of Research Operations and Portfolio Strategy"}]}}}